K284-3845 Screening compound: ethyl 8-[({4-oxo-3-[3-(piperidin-1-yl)propyl]-3,4-dihydroquinazolin-2-yl}sulfanyl)methyl]-2,4-dihydro-1,3-benzodioxine-6-carboxylate

K284-3845 Screening compound: ethyl 8-[({4-oxo-3-[3-(piperidin-1-yl)propyl]-3,4-dihydroquinazolin-2-yl}sulfanyl)methyl]-2,4-dihydro-1,3-benzodioxine-6-carboxylate
K284-3845 Screening compound: ethyl 8-[({4-oxo-3-[3-(piperidin-1-yl)propyl]-3,4-dihydroquinazolin-2-yl}sulfanyl)methyl]-2,4-dihydro-1,3-benzodioxine-6-carboxylate alternative view

Chemical Structure Depiction of ChemDiv screening compound K284-3845
ethyl 8-[({4-oxo-3-[3-(piperidin-1-yl)propyl]-3,4-dihydroquinazolin-2-yl}sulfanyl)methyl]-2,4-dihydro-1,3-benzodioxine-6-carboxylate

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

K284-3845

Molecular Formula

C28H33N3O5S (C28 H33 N3 O5 S)

Compound Name

ethyl 8-[({4-oxo-3-[3-(piperidin-1-yl)propyl]-3,4-dihydroquinazolin-2-yl}sulfanyl)methyl]-2,4-dihydro-1,3-benzodioxine-6-carboxylate

IUPAC name

ethyl 8-[({4-oxo-3-[3-(piperidin-1-yl)propyl]-34-dihydroquinazolin-2-yl}sulfanyl)methyl]-24-dihydro-13-benzodioxine-6-carboxylate

SMILES

CCOC(c1cc(CSC(N2CCCN3CCCCC3)=Nc(cccc3)c3C2=O)c2OCOCc2c1)=O

InChI

InChI=1S/C28H33N3O5S/c1-2-35-27(33)20-15-21-17-34-19-36-25(21)22(16-20)18-37-28-29-24-10-5-4-9-23(24)26(32)31(28)14-8-13-30-11-6-3-7-12-30/h4-5,9-10,15-16H,2-3,6-8,11-14,17-19H2,1H3

InChI Key

QZLHCPHNSNUWSG-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD15087979

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

523.65

Hydrogen Bond Acceptors Count

10.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

4.517

Distribution Coefficient, logD

2.751

Water Solubility, LogSw

-4.17

Polar Surface Area

67.375

Acid Dissociation Constant (pKa)

25.78

Base Dissociation Constant (pKb)

9.16

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

46.40

K284-3845 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Regenerative Medicine Focused Library (23016 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Targets:
  • Phosphatases

References: we are preparing a list of scientific research reports with K284-3845 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound K284-3845?
Check Price and Availability of K284-3845, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of K284-3845 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for K284-3845
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for K284-3845
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of K284-3845 available by request